Cancer Diagnosis Program Funds specimen resources and research to characterize tumors |
Radiation Research Program Funds novel radiotherapy research |
|||
Cancer Imaging Program Evaluates imaging in diagnosis, disease staging, and treatment monitoring |
Translational Research Program Integrates scientific advancements in the understanding of the biology of human cancer |
|||
Cancer Therapy Evaluation Program Assesses new anticancer agents, radiation treatments, and surgical methods |
Biometric Research Branch Provides statistical and biomathematical analyses |
|||
Developmental Therapeutics Program Funds drug discovery and development and provides related services |
Office of Cancer Complementary and Alternative Medicine Improves the quality of cancer research on complementary and alternative modalities |
The Division of Cancer Treatment and Diagnosis (DCTD) focuses its activities on developing novel diagnostics and therapies for cancer. DCTD staff members, along with colleagues throughout the National Cancer Institute (NCI), academia, and industry, are working to generate More…
Ten Years of Tamoxifen Reduces Breast Cancer Recurrences, Improves Survival (The ATLAS Trial)
Chemotherapy after Surgery Improves Survival When Some Breast Cancers Return (The CALOR Trial)
NIH Study Uncovers New Mechanism of Action for Class of Chemotherapy Drugs
Study Urges Caution on Source of Unrelated Donor Stem Cell Transplants
Imatinib May Help Treat Aggressive Lymphoma
Treatment Options for HER2-Positive Breast Cancer Expand and Evolve
NCI’s Clinical Trials Cooperative Groups
National Meeting Report